A detailed history of Grove Bank & Trust transactions in Embecta Corp. stock. As of the latest transaction made, Grove Bank & Trust holds 4 shares of EMBC stock, worth $76. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$76
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$12.51 - $20.83 $50 - $83
4 New
4 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.11B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.